Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Magnetic Particle Imaging Market: By Product Type, By Application, By End-User and Region Forecast 2020-2031
Magnetic Particle Imaging Market size was valued at US$ 166.8 million in 2024 and is expected to reach US$ 855.3 million by 2031, growing at a significant CAGR of 26.3% from 2025-2031. Moreover, the U.S. Global Magnetic Particle Imaging Market is projected to grow significantly, reaching an estimated value of US$ 248.9 Million by 2031. Magnetic Particle Imaging (MPI) is an advanced imaging technique that uses magnetic fields to capture high-resolution, real-time images of the body's internal structures. Unlike traditional imaging methods such as MRI or X-ray, MPI utilizes superparamagnetic nanoparticles as tracers to generate detailed images without the need for harmful ionizing radiation. The technology offers high spatial and temporal resolution, enabling real-time imaging for medical applications, particularly in the fields of oncology, neurology, and cardiovascular diagnostics.
The market is rapidly evolving, driven by increasing demand for non-invasive imaging techniques that offer superior resolution and safety compared to conventional methods. The market is gaining momentum due to the ability of MPI to provide high-quality, real-time imaging without the risks associated with radiation exposure. Key applications of MPI include diagnostic imaging for early disease detection, therapeutic monitoring, and pre-surgical planning. The growing focus on personalized medicine, combined with advancements in MPI technology, is expected to fuel market growth.
Based on the product type:
Among the product types, MPI Scanners are anticipated to lead the market due to their rising significance as a breakthrough imaging technology offering high-resolution, real-time, and radiation-free diagnostics. As healthcare providers increasingly prioritize non-invasive imaging methods, MPI scanners present a safer alternative compared to traditional CT and PET scans, especially in sensitive applications such as cardiovascular imaging and pediatric diagnostics. Furthermore, the ability of MPI to track magnetic nanoparticles with superior contrast and without background noise significantly enhances its clinical value. Research institutions and imaging technology developers are investing in the development of compact and efficient MPI scanners, indicating strong commercial potential and adoption ahead.
Based on the application:
Among the applications, cancer diagnosis is anticipated to lead the magnetic particle imaging (MPI) market due to the growing global burden of cancer and the urgent need for more accurate, early-stage diagnostic tools. MPI offers high sensitivity in detecting tumours using superparamagnetic nanoparticles, providing clear images without radiation exposure. This makes it especially beneficial in tracking cancer progression and evaluating treatment response. Its real-time imaging capability enables clinicians to detect even minute cancerous changes with precision. As demand for personalized and non-invasive diagnostic techniques rises, MPI’s advantages in oncology make it a key driver for market growth in cancer diagnosis applications.
Based on the end user:
Based on the end user, the hospitals segment is anticipated to lead the Magnetic Particle Imaging (MPI) market due to their advanced infrastructure, high patient inflow, and greater capacity for adopting cutting-edge imaging technologies. Hospitals are increasingly integrating MPI systems into their diagnostic departments to enhance imaging accuracy, particularly for complex conditions like cancer and neurological disorders. The presence of multidisciplinary teams in hospital settings further supports the interpretation and application of MPI findings in clinical decision-making. Additionally, the increasing investments in hospital-based research and advanced diagnostic solutions contribute to the dominance of this segment in the overall market landscape.
Study Period
2025 - 2031Base Year
2024CAGR
26.3%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
One of the primary drivers of the magnetic particle imaging (MPI) market is the increasing demand for non-invasive and radiation-free diagnostic imaging technologies. Traditional imaging techniques such as X-rays, CT scans, and MRIs involve exposure to ionizing radiation, which has raised concerns regarding patient safety, especially in repeated imaging procedures. MPI offers a significant advantage by providing high-resolution images without the need for harmful radiation. This makes it particularly appealing for applications in oncology, cardiology, and neurology, where frequent monitoring is required. The ability to track real-time processes in the body without radiation exposure is accelerating the adoption of MPI in medical settings. Additionally, MPI's ability to capture high-quality images with rapid temporal resolution is driving its demand among healthcare providers focused on patient safety and diagnostic accuracy.
A key restrainer for the market is the high cost of implementing MPI technology. Unlike traditional imaging systems, which are well-established and have lower upfront costs, MPI systems are relatively new and require specialized equipment and materials, such as superparamagnetic nanoparticles. The initial investment for hospitals and medical centres to adopt MPI systems can be prohibitively expensive, which has slowed the widespread adoption of this technology, especially in emerging markets with budget constraints. Furthermore, the maintenance and operational costs associated with MPI systems can be substantial due to the need for highly skilled professionals and specialized support. As a result, the high cost remains a significant barrier to entry for smaller medical institutions, limiting the growth potential of the market.
An exciting opportunity for the MPI market lies in its potential applications in personalized medicine. With advancements in medical technologies and a growing focus on tailor-made treatments, MPI can provide precise, real-time imaging for monitoring disease progression and evaluating individual patient responses to treatment. Personalized medicine relies heavily on accurate imaging to guide therapy decisions, and MPI’s non-invasive nature makes it an ideal candidate for real-time monitoring of treatment efficacy. MPI can be particularly beneficial in oncology, where early detection and precise monitoring of tumour behaviour can significantly impact patient outcomes. As the healthcare industry moves toward more personalized and patient-centred approaches, the demand for MPI technology is expected to grow, presenting a substantial growth opportunity for the market.
A prominent trend in the market is the growing integration of MPI with other imaging technologies to enhance diagnostic accuracy. While MPI offers excellent real-time imaging, its resolution may not always match that of traditional techniques like MRI or CT scans. To overcome this, there is a trend toward combining MPI with other modalities, such as MRI, to provide complementary information. Hybrid imaging systems, where MPI works alongside MRI or PET, are being developed to take advantage of the strengths of each method. This integration allows for more comprehensive imaging capabilities, enabling healthcare providers to make better-informed decisions regarding diagnosis and treatment planning. As these hybrid systems gain popularity, they are expected to contribute significantly to the market's growth and adoption in clinical settings.
Report Benchmarks |
Details |
Report Study Period |
2025 - 2031 |
Market Size in 2024 |
US$ 166.8 million |
Market Size in 2031 |
US$ 855.3 million |
Market CAGR |
26.3% |
By Product Type |
|
By Application |
|
By End User |
|
By Region |
|
According to PBI Analyst, the Magnetic Particle Imaging (MPI) market is poised for significant growth, driven by its ability to provide real-time, high-resolution imaging without ionizing radiation. As a novel modality, MPI is gaining attention in applications such as cancer diagnosis, vascular imaging, and cell tracking due to its superior sensitivity and safety. Hospitals and research institutions are increasingly adopting MPI technology, supported by rising investments in medical imaging innovation. While the market is still in its early stages, ongoing technological advancements and collaborations between academia and industry are expected to accelerate commercialization. North America currently leads, but Asia-Pacific is emerging rapidly with strong R&D momentum
Download Free Sample Report
The magnetic particle imaging market size was valued at US$ 166.8 million in 2024 and is projected to grow at a significant CAGR of 26.3% from 2025-2031.
The rising demand for radiation-free, real-time imaging in disease diagnostics is propelling the market.
Integration of MPI with hybrid imaging systems is emerging as a key technological trend enhancing diagnostic precision.
Asia-pacific is the fastest-growing region in the market.
1.Executive Summary |
2.Global Magnetic Particle Imaging Market Introduction |
2.1.Global Magnetic Particle Imaging Market - Taxonomy |
2.2.Global Magnetic Particle Imaging Market - Definitions |
2.2.1. Product Type |
2.2.2.Application |
2.2.3. End User |
2.2.4.Region |
3.Global Magnetic Particle Imaging Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Magnetic Particle Imaging Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Magnetic Particle Imaging Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
5.1. Magnetic Resonance Imaging |
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Positron Emission Tomography |
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. MPI Scanner |
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. CT |
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6.Global Magnetic Particle Imaging Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
6.1. Cancer Diagnosis |
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Neuro Imaging |
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Trauma Imaging |
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Vascular Imaging |
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Perfusion Imaging |
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Cell Tracking |
6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Inflammation Imaging |
6.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Others |
6.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
7.Global Magnetic Particle Imaging Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic Centres |
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Specialty Clinics |
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Magnetic Particle Imaging Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Magnetic Particle Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
9.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Magnetic Resonance Imaging |
9.1.2.Positron Emission Tomography |
9.1.3.MPI Scanner |
9.1.4.CT |
9.1.5.Others |
9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Cancer Diagnosis |
9.2.2.Neuro Imaging |
9.2.3.Trauma Imaging |
9.2.4.Vascular Imaging |
9.2.5.Perfusion Imaging |
9.2.6.Cell Tracking |
9.2.7.Inflammation Imaging |
9.2.8.Others |
9.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Diagnostic Centres |
9.3.3.Specialty Clinics |
9.3.4.Others |
9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Magnetic Particle Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Magnetic Resonance Imaging |
10.1.2.Positron Emission Tomography |
10.1.3.MPI Scanner |
10.1.4.CT |
10.1.5.Others |
10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Cancer Diagnosis |
10.2.2.Neuro Imaging |
10.2.3.Trauma Imaging |
10.2.4.Vascular Imaging |
10.2.5.Perfusion Imaging |
10.2.6.Cell Tracking |
10.2.7.Inflammation Imaging |
10.2.8.Others |
10.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Diagnostic Centres |
10.3.3.Specialty Clinics |
10.3.4.Others |
10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Magnetic Particle Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Magnetic Resonance Imaging |
11.1.2.Positron Emission Tomography |
11.1.3.MPI Scanner |
11.1.4.CT |
11.1.5.Others |
11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Cancer Diagnosis |
11.2.2.Neuro Imaging |
11.2.3.Trauma Imaging |
11.2.4.Vascular Imaging |
11.2.5.Perfusion Imaging |
11.2.6.Cell Tracking |
11.2.7.Inflammation Imaging |
11.2.8.Others |
11.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Diagnostic Centres |
11.3.3.Specialty Clinics |
11.3.4.Others |
11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Magnetic Particle Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Magnetic Resonance Imaging |
12.1.2.Positron Emission Tomography |
12.1.3.MPI Scanner |
12.1.4.CT |
12.1.5.Others |
12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Cancer Diagnosis |
12.2.2.Neuro Imaging |
12.2.3.Trauma Imaging |
12.2.4.Vascular Imaging |
12.2.5.Perfusion Imaging |
12.2.6.Cell Tracking |
12.2.7.Inflammation Imaging |
12.2.8.Others |
12.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Diagnostic Centres |
12.3.3.Specialty Clinics |
12.3.4.Others |
12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Magnetic Particle Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Magnetic Resonance Imaging |
13.1.2.Positron Emission Tomography |
13.1.3.MPI Scanner |
13.1.4.CT |
13.1.5.Others |
13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Cancer Diagnosis |
13.2.2.Neuro Imaging |
13.2.3.Trauma Imaging |
13.2.4.Vascular Imaging |
13.2.5.Perfusion Imaging |
13.2.6.Cell Tracking |
13.2.7.Inflammation Imaging |
13.2.8.Others |
13.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Diagnostic Centres |
13.3.3.Specialty Clinics |
13.3.4.Others |
13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.PerkinElmer Inc. |
14.2.2.Thermo Fisher Scientific |
14.2.3.Koninklijke Philips N.V. |
14.2.4.Hitachi Ltd |
14.2.5.Bruker |
14.2.6.Magnetic Insight, Inc. |
14.2.7.FUJIFILM Holdings Corporation |
14.2.8.GENERAL ELECTRIC COMPANY |
14.2.9.LI-COR Inc. |
14.2.10.Angstrom Advanced Inc. |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players